Author

Yanrong Sun

University of Pennsylvania

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Bingwei WangiD· 1 shared Ho Man ChaniD· 1 shared Janos Laszlo TanyiiD· 1 shared Jianfeng SheniD· 1 shared Jiao YuaniD· 1 shared Jie Sheng HuangiD· 1 shared Junjie JiangiD· 1 shared Kathleen T. MontoneiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bingwei WangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment

Youyou Zhang, Mu Xu, Jiao Yuan, Zhongyi Hu, Junjie Jiang, Yanrong Sun, Jie Sheng Huang, Yuxin Wang, Bingwei Wang, Jianfeng Shen, Meixiao Long, Yi Fan, Kathleen T. Montone, Janos Laszlo Tanyi, Sarah H. Kim, , Xiaowen Hu

This study identifies PRMT inhibitors as effective combinational therapies with PARP inhibitors to sensitize HR-proficient ovarian and breast cancer cells to treatment.

eLife · Jul 17, 2024Peer-reviewedCancer Biology